[HTML][HTML] Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
[HTML][HTML] Dexamethasone in hospitalized patients with Covid-19
RECOVERY Collaborative Group - New England Journal of …, 2021 - Mass Medical Soc
Abstract Background Coronavirus disease 2019 (Covid-19) is associated with diffuse lung
damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby …
damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby …
Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review
Importance The coronavirus disease 2019 (COVID-19) pandemic, due to the novel severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide sudden …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide sudden …
[HTML][HTML] Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
MAB Lucien, MF Canarie, PE Kilgore… - International journal of …, 2021 - Elsevier
The dissemination of COVID-19 around the globe has been followed by an increased
consumption of antibiotics. This is related to the concern for bacterial superinfection in …
consumption of antibiotics. This is related to the concern for bacterial superinfection in …
Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
several concerns were raised with respect to the veracity of the data and analyses
conducted by Surgisphere Corporation and its founder and our co-author, Sapan Desai, in …
conducted by Surgisphere Corporation and its founder and our co-author, Sapan Desai, in …
[HTML][HTML] Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Background Hydroxychloroquine and azithromycin have been used to treat patients with
coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these …
coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these …
[HTML][HTML] Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta …
Background Hydroxychloroquine or chloroquine with or without azithromycin have been
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …
Hydroxychloroquine for early treatment of adults with mild coronavirus disease 2019: a randomized, controlled trial
O Mitjà, M Corbacho-Monné, M Ubals… - Clinical Infectious …, 2021 - academic.oup.com
Background No effective treatments for coronavirus disease 2019 (COVID-19) exist. We
aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be …
aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be …
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants
Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty …
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty …
[HTML][HTML] Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
JD Chalmers, ML Crichton… - European respiratory …, 2021 - Eur Respiratory Soc
Introduction Hospitalised patients with coronavirus disease 2019 (COVID-19) as a result of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a high …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have a high …